Nitric Oxide Controls Fat Deposition in Dystrophic Skeletal Muscle by Regulating Fibro-Adipogenic Precursor Differentiation
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Duchenne muscular dystrophy (DMD) is an hereditary disease characterized by loss of muscle fibers and their progressive substitution by fat and fibrous tissue. Mesenchymal fibro-adipogenic progenitors (FAPs) expressing the platelet-derived growth factor receptor alpha (PDGFRα) are an important source of fibrosis and adipogenesis in dystrophic skeletal muscle. Among the therapies suggested for dystrophy are those based on nitric oxide (NO) donating drugs, the administration of which slows disease progression. NO has been shown to act by enhancing the regenerative potential of the diseased muscle. Whether it acts also by inhibiting fibrosis and adipogenesis was not known. Here, we show in vitro that NO regulates FAP fate through inhibition of their differentiation into adipocytes. In mdx mice, an animal model of DMD, treatment with the NO donating drug molsidomine reduced the number of PDGFRα+ cells as well as the deposition of both skeletal muscle fat and connective tissues. Inhibition of adipogenesis was due to NO-induced increased expression of miR-27b leading to downregulation of peroxisome proliferator-activated receptors gamma (Pparγ1) expression in a pathway independent of cGMP generation. These findings reveal an additional effect of NO in dystrophic muscle that conceivably synergizes with its known effects on regeneration improvement and explain why NO-based therapies appear effective in the treatment of muscular dystrophy. Stem Cells 2014;32:874–885
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis
Joe, A. W. B., Yi, L., Natarajan, A., Le Grand, F., So, L., Wang, J., Rudnicki, M. A., & Rossi, F. M. V. (2010) · Nature Cell Biology · doi:10.1038/ncb2015 · Cited by 1,690
Emery, A. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07815-7 · Cited by 1,667
Physiology of Nitric Oxide in Skeletal Muscle
Stamler, J. S., & Meissner, G. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.209 · Cited by 1,080 · cited 2×
“on muscle bioenergetics, glucose uptake and excitation contraction coupling remains also to be investigated [5, 26, 61-63].”
BackgroundType 2 Innate Signals Stimulate Fibro/Adipogenic Progenitors to Facilitate Muscle Regeneration
Heredia, J. E., Mukundan, L., Chen, F. M., Mueller, A. A., Deo, R. C., Locksley, R. M., Rando, T. A., & Chawla, A. (2013) · Cell · doi:10.1016/j.cell.2013.02.053 · Cited by 818 · cited 1×
“Investigation of the cellular and molecular effectors of the regeneration/degeneration switch is relatively recent and pathways and regulatory mechanisms still need to be identified in full [47, 48].”
BackgroundFibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle
Uezumi, A., Ito, T., Morikawa, D., Shimizu, N., Yoneda, T., Segawa, M., Yamaguchi, M., Ogawa, R., Matev, M. M., Miyagoe-Suzuki, Y., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.086629 · Cited by 680 · cited 4×
“To this substitution contributes significantly a population of mesenchymal fibro-adipogenic progenitors (FAPs) residing in the muscle, specifically located in the interstitial spaces [28-31].”
BackgroundInfluentialA nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice
Wehling, M., Spencer, M. J., & Tidball, J. G. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200105110 · Cited by 530 · cited 1×
“Restoration of NO generation by transgenic expression of nNOS in the mdx mouse model ameliorates its dystrophic phenotype [11, 12] and treatment with NO donating drugs reduces muscle necrosis as well”
BackgroundMitochondrial biogenesis by NO yields functionally active mitochondria in mammals
Nisoli, E., Falcone, S., Tonello, C., Cozzi, V., Palomba, L., Fiorani, M., Pisconti, A., Brunelli, S., Cardile, A., Francolini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405432101 · Cited by 495 · cited 1×
“on muscle bioenergetics, glucose uptake and excitation contraction coupling remains also to be investigated [5, 26, 61-63].”
BackgroundSelf-citationmicroRNA miR-27b impairs human adipocyte differentiation and targets PPARγ
Karbiener, M., Fischer, C., Nowitsch, S., Opriessnig, P., Papak, C., Ailhaud, G., Dani, C., Amri, E.-Z., & Scheideler, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.098 · Cited by 448
Defective myoblasts identified in Duchenne muscular dystrophy
Blau, H. M., Webster, C., & Pavlath, G. K. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.15.4856 · Cited by 335 · cited 1×
“When chronic damage occurs, such as in dystrophy, and compensative regeneration fails because of progressive exhaustion of the satellite cells pool [43-45], fibro-adipogenic degeneration becomes predominant, in a process termed “reparative disorder” [33].”
Background
Cited by
Adult stem cells at work: regenerating skeletal muscle
Schmidt, M., Schüler, S. C., Hüttner, S. S., von Eyss, B., & von Maltzahn, J. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03093-6 · Cited by 310
Duchenne Muscular Dystrophy: From Diagnosis to Therapy
Falzarano, M., Scotton, C., Passarelli, C., & Ferlini, A. (2015) · Molecules · doi:10.3390/molecules201018168 · Cited by 292
NAD + repletion improves muscle function in muscular dystrophy and counters global PARylation
Ryu, D., Zhang, H., Ropelle, E. R., Sorrentino, V., Mázala, D. A. G., Mouchiroud, L., Marshall, P. L., Campbell, M. D., Ali, A. S., Knowels, G. M., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf5504 · Cited by 256
“The number of FAP cells is higher in both mdx and mdx/Utr mice, causing the deposition of both skeletal muscle fat and connective tissues (37, 38).”
BackgroundRedox Control of Skeletal Muscle Regeneration
Le Moal, E., Pialoux, V., Juban, G., Groussard, C., Zouhal, H., Chazaud, B., & Mounier, R. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6782 · Cited by 195
“…long-term treatment of dystrophic mice with HCT 1026, a nitric oxide-releasing derivative of flurbiprofen, ameliorates the morphological, biochemical, and functional phenotype of the diseased muscle (45) through a decrease of the number of inflammatory cells and FAPs, thus reducing fibrosis (74).”
Jiang, D., Correa-Gallegos, D., Christ, S., Stefanska, A., Liu, J., Ramesh, P., Rajendran, V., De Santis, M. M., Wagner, D. E., & Rinkevich, Y. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0073-8 · Cited by 181
Metadata
- Authors
- Cordani, N., Pisa, V., Pozzi, L., Sciorati, C., & Clementi, E.
- Venue
- Stem Cells
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-03-17
- Volume
- 32
- Issue
- 4
- Pages
- 874-885
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W1547864103
- Cited by
- 91
- References
- 16
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nitric Oxide Controls Fat Deposition in Dystrophic Skeletal Muscle by Regulating Fibro-Adipogenic Precursor Differentiation. https://app.cochat.ai/papers/10.1002/stem.1587
- The paper
- Cordani, N., Pisa, V., Pozzi, L., Sciorati, C., & Clementi, E. (2014). Nitric Oxide Controls Fat Deposition in Dystrophic Skeletal Muscle by Regulating Fibro-Adipogenic Precursor Differentiation. Stem Cells. https://doi.org/10.1002/stem.1587
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.